There is potential for an ongoing relationship between The Australian and Medicines Australia to have an influence on editorial policy, writes Tim Woodruff.
Medicines Australia
Alarm over pharma-sponsored journalism at The Australian
Journalism leaders and researchers have raised concerns about a deal between the pharma industry group Medicines Australia and The Australian, which has led to direct sponsorship of health journalism.
Diagnosing relations between pharma, journalism and doctors
Last month the CEO of Medicines Australia launched a stinging attack on pharmaceutical industry critics but recent developments tend to undermine his arguments. Melissa Sweet reports.
Baker drug deal found in breach
For every Plavix script in 2009, Sanofi-Aventis agreed to donate 25 cents to support the Baker’s research and health programs. Upshot? A slap on the wrist and a $25,000 fine.
Never mind the politicians, what about funded trips for doctors?
Amidst all the public angst about politicians accepting trips and other gifts, these practices continue unabated amongst the medical profession, writes Melissa Sweet.
Medicines Australia: Time for a crackdown on junkets
There is no reason why appropriate standards of conduct should not be enforceable for all pharmaceutical companies, writes Ian Chalmers.
The ties that bind: how big pharma buys a good press
While efforts are underway in Australia and elsewhere to disentangle the ties between doctors and drug companies (as reported in Crikey yesterday), the spotlight should also be illuminating another influential profession’s conflicts of interest.
